Re: “Medical management of osteoarthritis of the knee and hip joints”, a Clinical Update article by Grainger R and Cicuttini FM in the 1 March 2004 issue of the Journal (Med J Aust 2004: 180; 232-236). The authors have requested a correction because their statement “both diclofenac and celecoxib are more COX-2 selective than meloxicam” is incorrect, and should read “both meloxicam and celecoxib are more COX-2 selective than diclofenac.”
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Department of Rheumatology, Alfred Hospital, Prahran, VIC.
- 1. Warner TD, Giullano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A 1999; 96: 7563-7568.